Literature DB >> 15162638

Psychopharmacologic treatment of aggression in children and adolescents.

Steven Ruths1, Hans Steiner.   

Abstract

Knowledge regarding psychopharmacology is increasingly based on clinical trials and rational algorithms. Medications are increasingly regarded as useful adjuncts in the treatment of maladaptive aggression, whether it appears as a target symptom or as a complication of a whole range of psychopathology. Properly integrated into a treatment package that uses psychotherapies and environmental manipulation, medications can provide relief from one of the most destructive forms of psychopathology. Still, more controlled clinical trials are needed, especially those comparing active interventions and those testing the synergistic and antagonistic effects of different treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162638     DOI: 10.3928/0090-4481-20040501-10

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  5 in total

1.  A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.

Authors:  Leo Bastiaens
Journal:  Community Ment Health J       Date:  2008-07-03

Review 2.  Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis.

Authors:  Eric A Youngstrom; Boris Birmaher; Robert L Findling
Journal:  Bipolar Disord       Date:  2008-02       Impact factor: 6.744

3.  Treating persistent adolescent aggression.

Authors:  John Peterson; Christopher Sheldon
Journal:  Curr Treat Options Neurol       Date:  2006-09       Impact factor: 3.972

4.  Psychopathology, trauma and delinquency: subtypes of aggression and their relevance for understanding young offenders.

Authors:  Hans Steiner; Melissa Silverman; Niranjan S Karnik; Julia Huemer; Belinda Plattner; Christina E Clark; James R Blair; Rudy Haapanen
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2011-06-29       Impact factor: 3.033

5.  Stimulant and atypical antipsychotic medications for children placed in foster homes.

Authors:  L Oriana Linares; Nuria Martinez-Martin; F Xavier Castellanos
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.